About OncoGenex



OncoGenex to Report Year End 2016 Financial Results on Feb. 23, 2017

Thursday, Feb 16 2017

OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement

Thursday, Jan 5 2017

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2016

Thursday, Nov 10 2016

OncoGenex to Report Third Quarter 2016 Financial Results on Nov. 10, 2016

Thursday, Nov 3 2016

OncoGenex Announces Positive Survival Results from Apatorsen Phase 2 Borealis-2™ Trial in Metastatic Bladder Cancer

Tuesday, Oct 25 2016

OncoGenex Announces Results from the Phase 3 ENSPIRIT Trial of Custirsen in Non-Small Cell Lung Cancer

Thursday, Oct 13 2016

OncoGenex Announces Results from the Phase 3 AFFINITY Trial of Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer

Tuesday, Aug 16 2016


External Link Pop Up Window

You are now exiting the OncoGenex Web site and entering a third party Web site.

OncoGenex does not review the information contained on the following Web site for content, accuracy or completeness. Use of and access to the information are subject to the terms, limitations and conditions set by the Web site producer. OncoGenex makes no claims about the accuracy or any other aspect of the information contained on this Web site, nor does OncoGenex necessarily endorse this Web site.

Stay on OncoGenex Continue